References
P. P. Speiser,Methods Find. Exp. Clin. Pharmacol., No. 13, 337–342 (1991).
J. Kreuter,Colloidal Drug Delivery Systems, Marcel Dekker, New York (1994).
Y. K. Oh, D. E. Nix, and R. M. Straubinger,Antimicrob. Agents Chemother., No. 39, 2104–2111 (1995).
J. Kreuter,Eur. J. Drug Metab. Pharmacokinet.,19, 253–256 (1994).
G. Thews, E. Mutschler, and P. Vaupel,Anatome, Physiologie, Pathophysiologie des Menschen, Wissenschaftliche, Stuttgart (1980).
T. Yoshioka, M. Hashida, S. Mutanishi, et al.,Int. J. Pharm., No. 8, 131–133 (1981).
J. Kreuter and P. P. Speiser,J. Pharm. Sci.,65, 1624–1630 (1976).
P. Couvreur, B. Kante, M. Roland, and P. P. Spieser,J. Pharm. Sci.,68, 1521–1527 (1979).
R. Diepold, J. Kreuter, J. Himber, et al.,Graefes, Arch. Clin. Exp. Ophthlmol.,227, 188–193 (1989).
L. Grislain, P. Couvreur, V. Lenaerts, et al.,Int. J. Pharm.,15, 335–342 (1983).
R. H. Muller, C. Lherm, J. Herbot, and P. Couvreur,Biomater.,11, 590–599 (1992).
V. Schafer, H. Briesen, H. Rubsamen-Waigmann, et al.,J. Microencasul.,67, 18–23 (1994).
R. Gref, Y. Minamitake, M. T. Peracchia, et al.,Science, No. 263, 1600–1603 (1994).
J. Kreuter, U. Tauber, and V. Illi,J. Pharm. Sci.,68, 1443–1450 (1979).
J. Kreuter, in:Drug Targeting, P. Buri and A. Gumma (eds.), Elseiver, Amsterdam (1985), pp. 51–68.
P. G. Waser, U. Muller, J. Kreuter, et al.,Int. J. Pharm.,39, 213–219 (1987).
V. Lenaerts, J. F. Nagelkerke, T. J. C. van Berkel, et al.,J. Pharm. Sci.,73, 980–988 (1984).
M. Demoy, S. Gibaud, J. P. Andreux, et al.,Pharm. Res.,14 463–468 (1997).
S. Gibaud, M. Demoy, J. P. Andreux, et al.,J. Pharm. Sci.,85, 944–950 (1996).
A. Ya. Sherstov, G. Ya. Kivman, A. E. Vasil'ev, et al.,Abstr. of Papers. The 3rd Conf. Pharm. Sci. Clin. Pharm., Jerusalem (1990), p. 26.
J. Kreuter, S. N. Mills, and S. S. Davis,Int. J. Pharm.,16, 105–113 (1983).
G. Barrat,Adv. Drug. Deliv. Rev.,16, 125–348 (1995).
G. Brochard and J. Kreuter,J. Drug Target.,1, 15–22 (1993).
J. F. Scieszka, L. L. Maggiora, S. D. Wright,Pharm. Res.,8, 65–71 (1991).
N. M. Wassef, G. R. Matyas, and C. R. Alving,Biochem. Biophys. Res. Commun.,176, 866–871 (1991).
S. D. Troster and J. Kreuter,J. Microencapsul.,9, 19–26 (1992).
D. J. Wilkins,J. Colloid Interface Sci.,25, 84–87 (1987).
G. Brochard and J. Kreuter,Pharm. Res.,13, 1055–1058 (1996).
G. Barrat,Eur. J. Pharm. Biopharm.,41, 1–80 (1995).
L. Illum, S. S. Davis, R. H. Muller, et al.,Life Sci.,40, 367–371 (1987).
G. Brochard, L. Kenneth, S. Fenglin, and J. Kreuter,Int. J. Pharm., No. 110, 29–35 (1994).
R. Alyautdin, D. Gothier, V. Petrov, et al.,Eur. J. Pharm. Biopharm., No. 41, 44–48 (1995).
P. Maincent, P. Thouvenot, C. Amicable, et al.,Pharm. Res.,9, 1534–1539 (1992).
P. Couvreur, L. Grislain, V. Lenaerts, et al., in:Polymeric Nanoparticles and Microspheres, P. Guiot and P. Couvreur (eds.), Fla. CRC Press, Boca Raton (1986), pp. 27–35.
J. Kreuter,Adv. Drug Deliv. Rev,7, 71–84 (1991).
H. O. Alpar, W. N. Field, R. Hyde, and D. A. Lewis,J. Pharm. Pharmacol.,41, 194–202 (1989).
P. Jani, G. W. Halbert, J. Langridge, and A. T. Florence,J. Pharm. Pharmacol.,42, 821–827 (1990).
M. P. Desai, V. Labhasetwar, G. L. Amidon, and R. J. Levy,Pharm. Res.,13, 1883–1845 (1996).
C. Pimienta, V. Lenaerts, C. Cadieux, et al.,Pharm. Res.,7, 49–57 (1990).
I. Sjoholm and P. Edman,J. Pharmacol. Exp. Ther.,211, 656–663 (1979).
C. Lam and G. E. Mathison,J. Med. Microbiol.,15, 373–379 (1982).
P. Couvreur, E. Fattal, and A. Andremont,Pharm. Res., No. 8, 1079–1086 (1991).
C. Losa, P. Calvo, E. Castro, et al.,J. Pharm. Pharmacol.,43, 548–552 (1991).
P. Couvreur, E. Fattal, H. Alphandary, et al.,J. Controlled Release,19, 259–264 (1992).
Q. Zhang and G. T. Liao,Yao Hsueh Hsueh Pao,30, 459–465 (1995).
M. Fresta, G. Puglisi, G. Giammona, et al.,J. Pharm. Ssci.,84, 895–902 (1995).
M. Youssef, E. Fattal, M.-J. Alonso, et al.,Antimicrob. Agents Chemother.,32, 1204–1211 (1988).
E. Fattal, M. Youssef, P. Couvreur, et al.,Antimicrob. Agents Chemother.,33, 1540–1546 (1989).
E. Fattal, J. Rojas, A. Andremont, and P. Couvreur,Antimicrob. Agents Chemother.,35, 770–777 (1991).
V. Shafer, H. Briesen, R. Andreesen, et al.Pharm. Res.,9, 541–548 (1992).
O. Balland, H. Pinto-Alphandary, E. Viron, et al.,J. Antimicrob. Chemother.,37, 105–115 (1996).
H. Pinto-Alphandary, O. Balland, A. Viron, et al.,Abstrs. of the 3rd Jerusalem Conf. Pharm. Sci. Clin. Pharm., 24 (1996).
C. Lherm, P. Couvreur, P. Loiseau, et al.J. Pharm. Pharmacol.,39, 650–655 (1987).
R. Gaspar, V. Preat, F. Opperdoes, et al.,Pharm. Res.,9, 782–790 (1992).
M. De Schrijver, K. Streule, R. Senekowitsch, et al.,Nucl. Med. Commun.,8, 895–901 (1987).
E. M. Gipps, P. Jaffray, and J. Dellattre,Int. J. Pharm.,40, 23–32 (1987).
R. Urrusino-Fernandez, E. Fattal, J. M. Rodrigues, et al.,J. Biomed. Mater. Res.,31, 401–408 (1996).
R. Urrusino-Fernandez, E. Fattal, J. Feger, et al.,Biomaterials,18, 511–517 (1997).
R. Urrusino-Fernandez, E. Fattal, J. Feger, et al.,Toxicol. Appl. Pharmacol.,130, 272–279 (1995).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 32, No. 3, pp. 3–6, March, 1998.
Rights and permissions
About this article
Cite this article
Gulyaev, A.E., Ermekbaeva, B.A., Kivman, G.Y. et al. Nanoparticles as a vector for the directed delivery of antibiotics (a review). Pharm Chem J 32, 115–118 (1998). https://doi.org/10.1007/BF02464187
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02464187